The oncology world is buzzing with excitement. MET receptor targeting has burst onto the scene like a superhero arriving just when all hope seemed lost. This cellular pathway, once buried in academic journals, now commands center stage as the hottest ticket in precision medicine. Patients worldwide are discovering that their genetic lottery tickets might actually be winners. The Economic...